Vitamin B12 deficiency has been linked to neurological symptoms like head pain
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
Their effectiveness can depend on factors such as ingredient quality, dosage, formulation, lifestyle habits, and consistency of use
The timing of consumption also matters
Remember, self-administration of B-Complex Vitamin IV therapy or obtaining it from unregulated sources may pose risks to your health and should be avoided